Key Developments: LeMaitre Vascular Inc (LMAT.W)
6.20USD
29 Jan 2013
$0.18 (+2.99%)
$6.02
$6.07
$6.20
$6.07
500
149
$6.46
$5.01
Latest Key Developments (Source: Significant Developments)
Lemaitre Vascular Inc Issues Q2 2013 Guidance Above Analysts' Estimates; Raises FY 2013 Revenue Guidance; Reaffirms FY 2013 Operating Income Guidance
Lemaitre Vascular Inc announced that for the second quarter of 2013, it expects sales of $15.6 million, and operating income of $1.2 million. The Company also announced that it increased its fiscal 2013 sales guidance to $61.7 million and maintained its operating income guidance of $5.0 million. All guidance excludes the effects of changes in foreign currency exchange rates, acquisitions and divestitures. According to I/B/E/S Estimates, analysts were expecting the Company to report revenues of $15.5 million and EBIT of $1.1 million for the second quarter of 2013; revenues of $61.2 million and EBIT of $4.43 million for fiscal 2013. Full Article
Lemaitre Vascular Inc Issues Q1, FY 2013 Guidance Above Analysts' Estimates
Lemaitre Vascular Inc announced that for the first quarter of 2013, it expects sales of $15.0 million and operating income of $0.7 million. For fiscal 2013, it expects sales of $61.5 million and operating income of $5.0 million. According to I/B/E/S Estimates, analysts were expecting the Company to report revenue of $14.00 million and EBIT of $0.44 million for the first quarter of 2013; revenue of $60.0 million and EBIT of $4.23 million for fiscal 2013. Full Article
Lemaitre Vascular Inc Declares Quarterly Dividend
Lemaitre Vascular Inc announced that the Board of Directors approved the payment of a quarterly cash dividend of $0.025 per share of common stock. The dividend will be paid on December 4, 2012 to shareholders of record on November 20, 2012. Full Article
LeMaitre Vascular, Inc. Issues Q3 2012 Guidance; Revenue Guidance Below Analysts' Estimates; Reaffirms FY 2012 Guidance
LeMaitre Vascular, Inc. announced that for the third quarter of 2012, it expects sales of $13.9 million and operating income of $1.0 million. For fiscal 2012, it continues to expect sales of $57.0 million and operating income of $5.0 million. According to I/B/E/S Estimates, analysts were expecting the Company to report revenue of $14.20 million for the second quarter of 2012; and revenue of $56.90 million for fiscal 2012. Full Article
LeMaitre Vascular, Inc. Issues Q2 2012 Guidance Below Analysts' Estimates; Lowers FY 2012 Revenue Guidance; Reaffirms FY 2012 Operating Income Guidance
LeMaitre Vascular, Inc. announced second quarter 2012 sales of $14.2 million and reported operating income of $1.0 million. The Company also expects fiscal 2012 sales of $57.0 million and reported operating income of $5.0 million. The Company's fiscal 2012 top-line guidance has been revised downwards by $0.5 million to reflect the likely temporary loss of AlboGraft sales in the U.K and France. According to I/B/E/S Estimates, analysts were expecting the Company to report revenue of $14.40 million and operating profit of $1.2 million for the second quarter of 2012; and revenue of $57.30 million for fiscal 2012. Full Article
LeMaitre Vascular, Inc. Issues Q1 2012 Guidance; Lowers FY 2012 Guidance
LeMaitre Vascular, Inc. announced that for first quarter of 2012, it expects sales of $13.8 million (+8% organic compared to Q1 2011) and operating income of $0.8 million. For fiscal 2012, it expects sales of $57.5 million (+9% organic compared to 2011), and reported operating income of $5.0 million. Changes in foreign currency exchange rates since the Company's previous guidance lowered fiscal 2012 sales guidance by approximately $0.725 million. The Company's previous fiscal 2012 organic sales guidance was +8%. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenue of $59.1 million and operating profit of $7.6 million for fiscal 2012. Full Article
LeMaitre Vascular, Inc. Doubles Stock Repurchase Program From $5 Million To $10 Million
LeMaitre Vascular, Inc. announced that its Board of Directors has doubled its stock repurchase authorization to an aggregate of $10 million of its Common Stock, to be purchased from time to time in the open market or in privately negotiated transactions. The authority for the repurchase program has been extended for two years until December 31, 2013, unless earlier suspended or discontinued or unless further extended by the Company's Board of Directors. The program is funded by the Company's cash and cash equivalents. Full Article
LeMaitre Vascular, Inc. Issues Q4 2011 And FY 2012 Guidance Below Analysts' Estimates; Declares Quarterly Cash Dividend
LeMaitre Vascular, Inc. announced that it expects fourth quarter 2011 sales of $14.2 million and reported operating income of $1.2 million. The Company also expects fiscal 2012 sales of $59.0 million, and reported operating income of $6.0 million. The Company's fourth quarter 2011 and fiscal 2012 guidance includes the effects of its exit from stent grafts. According to I/B/E/S Estimates, analysts were expecting the Company to report revenue of $14.4 million and operating profit of $1.5 million for the fourth quarter 2011; revenue of $61.6 million and operating profit of $7.9 million for fiscal 2012. The Company also announced that the Board of Directors have approved the payment of a quarterly cash dividend on the Company's common stock of $0.02 per share, with payment to be made on December 6, 2011, to shareholders of record at the close of business on November 23, 2011. Full Article
LeMaitre Vascular, Inc. Declares Quarterly Cash Dividend
LeMaitre Vascular, Inc. announced that the Board of Directors approved the payment of a quarterly cash dividend on the Company's common stock of $0.02 per share, with payment to be made on September 6, 2011 to shareholders of record at the close of business on August 19, 2011. Full Article
LeMaitre Vascular, Inc. Issues Q3 2011 Guidance Below Analysts' Estimates; Lowers FY 2011 Guidance
LeMaitre Vascular, Inc. announced that for the third quarter of 2011, it expects sales of $14.6 million and reported operating income of $1.5 million. The Company also expects 2011 sales of $58.7 million and reported operating income of $4.0 million. According to I/B/E/S Estimates, analysts are expecting the Company to report revenues of $14.7 million and EBIT of $1.90 for the third quarter of 2011; revenues $59 million and EBIT of $7.05 for fiscal 2011. Full Article
Earnings vs. 
Estimates
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
